Clinical Trials · NCT02887625
Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Dr. Muhammad Abdulghani
- Enrollment
- 410
- Start date
- Feb 2015
- Locations
- 1 site, Qatar
- Primary endpoint
- HbA1c
Search for a command to run...